CONVERGENCE PHARMACEUTICALS LIMITED

09376285
Active Maidenhead

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CONVERGENCE PHARMACEUTICALS LIMITED

09376285

Research and experimental development on biotechnology

Founded 6 Jan 2015 Active Maidenhead, England 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

SILVER NEWCO CO LIMITED 6 Jan 2015 — 24 Apr 2015
Accounts Submitted 10 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 17 Jan 2026 Next due 20 Jan 2027 6 months remaining
Net assets £-14K £12K 2024 year on year
Total assets £4K £0 2024 year on year
Total Liabilities £18K £12K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Building 5 Foundation Park Roxborough Way Maidenhead Berkshire SL6 3UD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CONVERGENCE PHARMACEUTICALS LIMITED (09376285), an active life sciences and medical technology company based in Maidenhead, England. Incorporated 6 Jan 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2015–2024)

Cash in Bank

N/A

Net Assets

-£14.00k

Increased by £12.00k (+46%)

Total Liabilities

£18.00k

Decreased by £12.00k (-40%)

Turnover

N/A

Employees

N/A

Debt Ratio

450%

Decreased by 300 (-40%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 79,100,000 Shares £79.10m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Feb 201579,100,000£79.10m£79.10m

Officers

Officers

1 active 2 resigned
Status
Helen Elizabeth HanbyDirectorBritishEngland6021 Feb 2020Active

Shareholders

Shareholders (1)

Biogen Inc.
50.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Biogen Inc.

United States Of America

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CONVERGENCE PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Jan 2026Confirmation StatementConfirmation statement made on 6 Jan 2026 with no updates
23 Jul 2025OfficersTermination of Geronimo Martinez as director on 14 Jul 2025
23 Jul 2025OfficersAppointment of Amit Singh Purwaha as director on 14 Jul 2025
10 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
6 Jan 2025Confirmation StatementConfirmation statement made on 6 Jan 2025 with no updates
17 Jan 2026 Confirmation Statement

Confirmation statement made on 6 Jan 2026 with no updates

23 Jul 2025 Officers

Termination of Geronimo Martinez as director on 14 Jul 2025

23 Jul 2025 Officers

Appointment of Amit Singh Purwaha as director on 14 Jul 2025

10 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

6 Jan 2025 Confirmation Statement

Confirmation statement made on 6 Jan 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 6 Jan 2026 with no updates

5 months ago on 17 Jan 2026

Termination of Geronimo Martinez as director on 14 Jul 2025

11 months ago on 23 Jul 2025

Appointment of Amit Singh Purwaha as director on 14 Jul 2025

11 months ago on 23 Jul 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 10 Jun 2025

Confirmation statement made on 6 Jan 2025 with no updates

1 years ago on 6 Jan 2025